Quillaic acid

Quillaic acid (CAS No.: 631-01-6) is a triterpenoid sapogenin and the principal aglycone constituent of Quillaja saponaria derived saponins, and it is primarily classified as a natural product research tool for inflammation biology, cancer cell signaling, and membrane active adjuvant related pharmacology in preclinical discovery settings; current evidence from cell based studies and compound class level analyses indicates that its bioactivity is associated with modulation of pro inflammatory signaling networks such as NF kappa B and cytokine linked pathways, regulation of apoptotic programs including caspase associated cell death processes, and suppression of proliferation in transformed cell systems, while reported potency is generally described qualitatively within nanomolar to micromolar or low micromolar concentration domains depending on assay format, cell lineage, and exposure duration rather than as universally transferable fixed values; in biomedical research workflows, quillaic acid is commonly used as a reference scaffold for structure activity relationship studies of Quillaja saponins, mechanistic interrogation of immune and inflammatory responses, and exploratory phenotypic screening in oncology relevant in vitro models, with follow on validation in animal models when appropriate, and the concentrations or doses used in experiments typically depend on specific experimental designs and research objectives, emphasizing that this material is intended exclusively for laboratory research use and mechanistic investigation and not for human use, clinical application, food related use, or any other non research purpose.